Eli Chan
Impact in
- Pharmacology top 0.1%
- Pharmacogenetics and Drug Metabolism
- Fungal Biology and Applications
- Pharmacological Effects of Natural Compounds
- Drug-Induced Hepatotoxicity and Protection
-
- Complementary and Alternative Medicine Studies
Papers in
-
- Cancer therapeutics and mechanisms 9
- Pharmacology 27
- Pharmacogenetics and Drug Metabolism 21
- Fungal Biology and Applications 9
- Pharmacological Effects of Natural Compounds 5
- Co-authors
- Shu‐Feng Zhou (21 shared papers)Wei Duan (26 shared papers)Min Huang (16 shared papers)Sui Yung Chan (12 shared papers)Shufeng Zhou (17 shared papers)Zeping Hu (10 shared papers)Hwee‐Ling Koh (4 shared papers)Yihuai Gao (10 shared papers)
- Journals
- Current Drug Metabolism (11 papers)Pharmaceutical Research (8 papers)European Journal of Pharmaceutical Sciences (6 papers)Journal of Chromatography B (5 papers)Journal of Pharmaceutical and Biomedical Analysis (3 papers)
- Partner nations
- SingaporeChinaNew Zealand
In The Last Decade
Eli Chan
76 papers receiving 3.8k citations
Eli Chan's Hit Papers
Peers
Comparison fields: 5 of 124
- Pharmacology 1.5k
- Complementary and alternative medicine 583
- Pharmacology 823
- Oncology 776
- Transplantation 70
Countries citing papers authored by Eli Chan
This map shows the geographic impact of Eli Chan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eli Chan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eli Chan more than expected).
Fields of papers citing papers by Eli Chan
This network shows the impact of papers produced by Eli Chan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eli Chan. The network helps show where Eli Chan may publish in the future.
Co-authors
The 25 scholars most cited alongside Eli Chan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 76 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Herb-Drug Interactions Hit paper breakdown → | 2005 | 500 |
| 2 | 2005 | 415 | |
| 3 | 2005 | 220 | |
| 4 | 2004 | 195 | |
| 5 | 2009 | 184 | |
| 6 | 2008 | 169 | |
| 7 | 2004 | 125 | |
| 8 | 2005 | 102 | |
| 9 | 2005 | 94 | |
| 10 | 1994 | 83 | |
| 11 | 2007 | 80 | |
| 12 | 2005 | 75 | |
| 13 | 2005 | 71 | |
| 14 | 2009 | 69 | |
| 15 | 2006 | 65 | |
| 16 | 2007 | 65 | |
| 17 | 2009 | 64 | |
| 18 | 2011 | 64 | |
| 19 | 2005 | 64 | |
| 20 | 2005 | 60 |
About Eli Chan
Eli Chan is a scholar working on Molecular Biology, Pharmacology, Oncology, Pharmacology and Pediatrics, Perinatology and Child Health, having authored 76 papers that have together received 4.0k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (21 papers), Drug Transport and Resistance Mechanisms (12 papers), Fungal Biology and Applications (9 papers), Cancer therapeutics and mechanisms (9 papers), Pharmacological Effects and Toxicity Studies (9 papers), Cancer Treatment and Pharmacology (8 papers), Pharmacological Effects of Natural Compounds (5 papers) and Renal Transplantation Outcomes and Treatments (4 papers). The work is most often cited by research in Pharmacology (1.5k citations), Complementary and alternative medicine (583 citations), Pharmacology (823 citations), Oncology (776 citations) and Transplantation (70 citations). Eli Chan has collaborated with scholars based in Singapore, China and New Zealand. Frequent co-authors include Shu‐Feng Zhou, Wei Duan, Min Huang, Sui Yung Chan, Shufeng Zhou, Zeping Hu, Hwee‐Ling Koh, Yihuai Gao, Boon Cher Goh and Xiaotian Li. Their work appears in journals such as Current Drug Metabolism, Pharmaceutical Research, European Journal of Pharmaceutical Sciences, Journal of Chromatography B and Journal of Pharmaceutical and Biomedical Analysis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.